Prognostic Significance of β-Myosin Heavy Chain Mutations is Reflective of Their Hypertrophic Expressivity in Patients with Hypertrophic Cardiomyopathy

Journal of Investigative Medicine

Volumn 45, Issue 4, 1997, Pages 191-196

  Abchee, Antoine ^a   Marian, Ali J ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Hypertrophic cardiomyopathy; Hypertrophy; Mutations; Prognosis; Sudden cardiac death

Indexed keywords

MYOSIN HEAVY CHAIN;

ADULT; ARTICLE; CHILD; ECHOCARDIOGRAPHY; FAMILY; FEMALE; GENETICS; GENOTYPE; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MALE; PATHOLOGY; POINT MUTATION; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; SUDDEN DEATH;

ADULT; CARDIOMYOPATHY, HYPERTROPHIC; CHILD; CHILD, PRESCHOOL; DEATH, SUDDEN, CARDIAC; ECHOCARDIOGRAPHY; FAMILY; FEMALE; GENOTYPE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MYOCARDIUM; MYOSIN HEAVY CHAINS; POINT MUTATION; POLYMERASE CHAIN REACTION;

EID: 0031114657     PISSN: 17088267     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Marian AJ, Roberts R. Recent advances in the molecular genetics of hypertrophic cardiomyopathy. Circulation 1995;92:1336-47.
2. Wynne J, Braunwald E. Heart disease: A textbook of cardiovascular medicine. In: Braunwald E, ed. The cardiomopathies and myocarditides: toxic, chemical, and physical damage to the heart. Philadelphia: W.B. Saunders Company, 1992:1394-450.
3. Maron BJ, Shirani J, Poliac LC, Mathenge R, Roberts WC, Mueller FO. Sudden death in young competitive athletes: clinical, demographic, and pathological profiles. JAMA 1996;276:199-204.
4. Marian AJ. Sudden cardiac death in hypertrophic cardiomyopathy: from bench to bedside with an emphasis on genetic markers. Clin Cardiol 1995;18:189-98.
5. Fananapazir L, Chang AC, Epstein SE, McAreavey D. Prognostic determinants in hypertrophic cardiomyopathy. Prospective evaluation of a therapeutic strategy based on clinical, Holter, hemodynamic, and electrophysiologic findings. Circulation 1992;86:730-40.
6. McKenna WJ, Camm AJ. Sudden cardiac death in hypertrophic cardiomyopathy. Assessment of patients at high risk. Circulation 1989;80:1489-92.
7. Geisterfer-Lawrance AA, Kass S, Tanigawa G, Vosberg HP, McKenna W, Seidman CE, Seidman JG. A molecular basis for familial hypertrophic cardiomyopathy: a β-cardiac myosin heavy chain gene missense mutation. Cell 1990;62:999-1006.
8. Thierfelder L, Watkins H, MacRae C, Lamas R, McKenna W, Vosberg H-P, Seidman JG, Seidman CE. α-Tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere. Cell 1994;77:701-12.
9. Watkins H, Conner D, Thierfelder L, Jarcho JA, MacRae C, McKenna WJ, Maron BJ, Seidman WJ, Seidman CE. Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy. Nature Genet 1995;11:434-7.
10. Bonne G, Carrier L, Bercovici J, Cruaud C, Richard P, Hainque B, Gautel M, Labeit S, James M, Beckmann J, Weissenbach J, Vosberg H-P, Fiszman M, Komajda M, Schwartz K. Cardiac myosin binding protein-C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy. Nature Genet 1995;11:438-40.
11. Watkins H, McKenna WJ, Thierfelder L, Suk HJ, Anan R, O'Donoghue A, Spirito P, Matsumori A, Moravec C, Seidman JG, Seidman CE. Mutations in the genes for cardiac troponin T and α-tropomyosin in hypertrophic cardiomyopathy. N Engl J Med 1995;332:1058-64.
12. Marian AJ, Mares A, Kelley D, Yu Q-T, Hill R, Perryman MB, Young RW, Roberts R. Sudden death in hypertrophic cardiomyopathy: genotype-phenotype correlation of β-myosin heavy chain mutations. Eur Heart J 1995;16:368-76.
13. Watkins H, Rosenzweig A, Hwang D, Levi T, McKenna W, Seidman CE, Seidman JG. Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. N Engl J Med 1992;326:1108-14.
14. 403Arg-Gln mutation. Circulation 1992;86:345-52.
15. Anan R, Greve G, Thierfelder L, Watkins HC, McKenna WJ, Solomon S, Vecchio C, Shono H, Nakao S, Tanaka H, Mares A Jr, Towbin JA, Spirito P, Roberts R, Seidman JG, Seidman CE. Prognostic implications of novel β-cardiac myosin heavy chain gene mutations that cause familial hypertrophic cardiomyopathy. J Clin Invest 1994;93:280-5.
16. Fananapazir L, Epstein ND. Genotype-phenotype correlation in hypertrophic cardiomyopathy: insights provided by comparisons of kindreds with distinct and identical β-myosin heavy chain gene mutations. Circulation 1994;89:22-32.
17. Hejtmancik JF, Brink PA, Towbin J, Hill R, Brink L, Tapscott T, Traktenbroit A, Roberts R. Localization of gene for familial hypertrophic cardiomyopathy to chromosome 14q1 in a diverse US population. Circulation 1991;83:1592-7.
18. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgessell H, Reichek N, Sahn D, Schnittger I, Silverman NH, Tajik AJ. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms: recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 1989;2:358-67.
19. Wigle ED, Sasson Z, Henderson MA, Ruddy TD, Fulop J, Rakowski H, Williams WG. Hypertrophic cardiomyopathy: the importance of the site and extent of hypertrophy: a review. Prog Cardiovasc Dis 1985;28:1-83.
20. Rakowski H, Sasson Z, Wigle ED. Echocardiographic and Doppler assessment of hypertrophic cardiomyopathy. J Am Soc Echocardiogr 1988;1:31-47.
21. Solomon SD, Wolff SA, Watkins H, Ridker PM, Come P, McKenna WJ, Seidman CE, Lee RT. Left ventricular hypertrophy and morphology in familial hypertrophic cardiomyopathy associated with mutations of the beta-myosin heavy chain gene. J Am Coll Cardiol 1993;22:498-505.
22. Maron BJ, Roberts WC, Epstein SE. Sudden death in hypertrophic cardiomyopathy: a profile of 78 patients. Circulation 1982;65:1388-94.
23. Spirito P, Maron BJ. Relation between extent of left ventricular hypertrophy and occurrence of sudden cardiac death in hypertrophic cardiomyopathy. J Am Coll Cardiol 1990;15:1521-6.
24. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 1990;322:1561-6.
25. Bikkina M, Levy D, Evans JC, Larson MG, Benjamin EJ, Wolf PA, Castelli WP. Left ventricular mass and risk of stroke in an elderly cohort: the Framingham Heart Study. JAMA 1994;272:33-6.
26. Sullivan JM, Vander Zwaag R, El-Zeky F, Ramanathan KB, Mirvis DM. Left ventricular hypertrophy: effect on survival. J Am Coll Cardiol 1993;22:508-13.
27. Adams TD, Yanowitz FG, Fisher AG. Ridges JD, Nelson AG, Hagan AD, Williams RR, Hunt SC. Heritability of cardiac size: an echocardiographic and electrocardiographic study of monozygotic and dizygotic twins. Circulation 1985;71:39-44.
28. Verhaaren HA, Schicken RM, Mosteller M, Hewitt JK, Eaves LJ, Nance WE. Bivariate genetic analysis of left ventricular mass and weight in pubertal twins (The Medical College of Virginia Twin Study). Am J Cardiol 1991;68:661-8.
29. Lechin M, Quinones M, Omran A, Hill R, Yu Q-T, Rakowski H, Wigle D, Liew CC, Sole M, Roberts R, Marian AJ. Angiotensin convening enzyme genotype DD is associated with increased left ventricular mass in patients with hypertrophic cardiomyopathy. Circulation 1995;92:1808-12.